MarketPeel
Insider Trading Intelligence
JB

Jon Christian Bates

NUTX
CHIEF FINANCIAL OFFICER · NUTEX HEALTH INC. · CIK 0001938758
FILING MIX · LIFETIME83%/17%
BUYS
15
SELLS
3
TOTAL VALUE
$221.7K
COMPANIES
1
ACTIVE SINCE
Apr 2023
HOLDINGS NOW
5,527
AVG SELL PX
TRADE KIND
SHOWING 18 / 18
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
4 backtested trades · 8 horizons · 4 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Jon Christian Bates, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d4+100.00%+24.96%+2.15%+22.80%+17.32%
14d4+100.00%+31.53%+1.39%+30.14%+25.64%
30d4+75.00%+23.45%+5.11%+18.34%+19.85%
60d4+75.00%+15.20%+7.41%+7.79%+10.75%
90d4+50.00%+6.65%+8.46%-1.82%+3.63%
180d4+50.00%+44.93%+17.18%+42.81%-7.40%
1y4(1 pending)+66.67%+87.35%+25.89%+61.45%-12.50%
2y4(3 pending)+100.00%+99.80%+38.58%+61.23%+61.23%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
NUTX · 5,527 shares · as of Mar 11, 2026
037,12974,258111,386148,515202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
FLOW · 15 buys / 3 sellsCOVERAGE · 12 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
NUTX
NUTEX HEALTH INC.
PURCHASE
Chief Financial Officer
1,6945,527Mar 11, 2026Mar 11, 2026View →
NUTX
NUTEX HEALTH INC.
PURCHASE
Chief Financial Officer
2,6678,305Mar 10, 2026Mar 11, 2026View →
NUTX
NUTEX HEALTH INC.
PURCHASE
Chief Financial Officer
750$136.71$102.5K5,638Nov 25, 2025Nov 28, 2025View →
NUTX
NUTEX HEALTH INC.
PURCHASE
Chief Financial Officer
1,000$81.81$81.8K4,888Apr 8, 2025Apr 14, 2025View →
NUTX
NUTEX HEALTH INC.
PURCHASE
Chief Financial Officer
3,5006,500Mar 10, 2025Apr 14, 2025View →
NUTX
NUTEX HEALTH INC.
PURCHASE
Chief Financial Officer
1112,388Mar 1, 2025Apr 14, 2025View →
NUTX
NUTEX HEALTH INC.
PURCHASE
Chief Financial Officer
1,5003,888Mar 1, 2025Apr 14, 2025View →
NUTX
NUTEX HEALTH INC.
PURCHASE
Chief Financial Officer
1,350$21.46$29.0K2,277Aug 22, 2024Aug 26, 2024View →
NUTX
NUTEX HEALTH INC.
PURCHASEGRANT
Stock grant
45,00048,301Jun 28, 2024Jun 28, 2024View →
NUTX
NUTEX HEALTH INC.
SALE
Chief Financial Officer
49,50549,505Mar 12, 2024Mar 14, 2024View →
NUTX
NUTEX HEALTH INC.
PURCHASE
Chief Financial Officer
49,505139,010Mar 12, 2024Mar 14, 2024View →
NUTX
NUTEX HEALTH INC.
PURCHASE
Chief Financial Officer
20,000$0.42$8.3K89,505Jun 15, 2023Jun 20, 2023View →
NUTX
NUTEX HEALTH INC.
PURCHASE
Chief Financial Officer
20,00069,505Apr 1, 2023May 10, 2023View →
NUTX
NUTEX HEALTH INC.
PURCHASEGRANT
Stock grant
20,00020,000Apr 1, 2023May 10, 2023View →
NUTX
NUTEX HEALTH INC.
SALE
Chief Financial Officer
20,0000Apr 1, 2023May 10, 2023View →
NUTX
NUTEX HEALTH INC.
PURCHASE
Chief Financial Officer
49,50549,505Apr 1, 2023May 10, 2023View →
NUTX
NUTEX HEALTH INC.
PURCHASEGRANT
Stock grant
148,515148,515Apr 1, 2023May 10, 2023View →
NUTX
NUTEX HEALTH INC.
SALE
Chief Financial Officer
49,50599,010Apr 1, 2023May 10, 2023View →
Other insiders · NUTX
Loading peer insiders…
About this filer
CIK 0001938758
ROLE
Chief Financial Officer
PRIMARY
NUTX
COMPANIES
1
ACTIVE SINCE
Apr 2023
MARKETPEEL · /INSIDER/0001938758DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback